10.08.2013 Views

Report in English with a Dutch summary (KCE reports 63A)

Report in English with a Dutch summary (KCE reports 63A)

Report in English with a Dutch summary (KCE reports 63A)

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

6 Breast Cancer <strong>KCE</strong> <strong>reports</strong> 63<br />

2 METHODOLOGY<br />

2.1 GENERAL APPROACH<br />

As for the cl<strong>in</strong>ical practice guidel<strong>in</strong>es (CPGs) for colorectal cancer and testicular cancer,<br />

the present CPG was developed by adapt<strong>in</strong>g (<strong>in</strong>ter)national CPGs to the Belgian context<br />

[1]. This approach is currently be<strong>in</strong>g structured <strong>in</strong> a formal methodology by the<br />

ADAPTE group, an <strong>in</strong>ternational group of guidel<strong>in</strong>e developers and researchers [2]. The<br />

ADAPTE methodology generally consists of three major phases:<br />

Set-up Phase: Outl<strong>in</strong>es the necessary tasks to be completed prior to beg<strong>in</strong>n<strong>in</strong>g the<br />

adaptation process (e.g., identify<strong>in</strong>g necessary skills and resources).<br />

Adaptation Phase: Assists guidel<strong>in</strong>e developers <strong>in</strong> mov<strong>in</strong>g from selection of a topic<br />

to identification of specific cl<strong>in</strong>ical questions; search<strong>in</strong>g for and retriev<strong>in</strong>g guidel<strong>in</strong>es;<br />

assess<strong>in</strong>g the consistency of the evidence there<strong>in</strong>, their quality, currency, content and<br />

applicability; decision mak<strong>in</strong>g around adaptation; and prepar<strong>in</strong>g the draft adapted<br />

guidel<strong>in</strong>e.<br />

F<strong>in</strong>alization Phase: Guides guidel<strong>in</strong>e developers through gett<strong>in</strong>g feedback on the<br />

document from stakeholders who will be impacted by the guidel<strong>in</strong>e, consult<strong>in</strong>g <strong>with</strong> the<br />

source developers of guidel<strong>in</strong>es used <strong>in</strong> the adaptation process, establish<strong>in</strong>g a process<br />

for review and updat<strong>in</strong>g of the adapted guidel<strong>in</strong>e and the process of creat<strong>in</strong>g a f<strong>in</strong>al<br />

document.<br />

This stepwise approach is currently be<strong>in</strong>g validated <strong>in</strong> an evaluation study us<strong>in</strong>g the<br />

(qualitative and quantitative) <strong>in</strong>formation from multiple case studies.<br />

2.2 CLINICAL QUESTIONS<br />

The cl<strong>in</strong>ical practice guidel<strong>in</strong>e addresses the follow<strong>in</strong>g cl<strong>in</strong>ical questions:<br />

1. Which screen<strong>in</strong>g strategy is the most effective for the early detection of<br />

breast cancer?<br />

a. < 50 years<br />

b. 50 – 69 years<br />

c. > 70 years<br />

2. What is the ideal follow-up (and treatment) of women <strong>with</strong> a high familial<br />

and/or genetic risk of develop<strong>in</strong>g breast cancer?<br />

3. What diagnostic tests are the most effective to confirm the diagnosis of<br />

breast cancer?<br />

a. Triple test approach: cl<strong>in</strong>ical exam<strong>in</strong>ation / mammography / pathology<br />

b. MRI?<br />

c. MIBI?<br />

4. What diagnostic tests are necessary to <strong>in</strong>vestigate the extent of the breast<br />

cancer?<br />

a. Sent<strong>in</strong>el biopsy<br />

b. X-ray heart/lungs<br />

c. Ultrasonography of the liver<br />

d. Bone sc<strong>in</strong>tigraphy<br />

e. Biochemical and tumormarkers; genetic tests<br />

f. CAT scan of the thorax<br />

g. PET scan

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!